Results 121 to 130 of about 15,375 (176)
New-Onset Primary Hypothyroidism in a 14-year-old Girl Presenting as Hemorrhagic Shock From Severe Menorrhagia. [PDF]
JCEM Case RepArias G +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Obstetrics and Gynecology Clinics of North America, 1990
Excessive vaginal bleeding, or menorrhagia, is one of the most common presenting symptoms for gynecologic patients. Although this disorder has many possible etiologies, it is generally possible to approach its diagnosis and management in an orderly fashion.
C A, Long, M J, Gast
openaire +2 more sources
Excessive vaginal bleeding, or menorrhagia, is one of the most common presenting symptoms for gynecologic patients. Although this disorder has many possible etiologies, it is generally possible to approach its diagnosis and management in an orderly fashion.
C A, Long, M J, Gast
openaire +2 more sources
Prostaglandins and Menorrhagia
Acta Obstetricia et Gynecologica Scandinavica, 1983This paper reviews the various theories offered to explain excessive menstrual blood losses whether these are of primary origin or induced by IUD. An increased concentration of prostaglandins in endometrial tissue at the onset of menstruation may contribute to heavy menstrual bleeding. The mechanism of action is not clear, but prostaglandins may affect
K G, Nygren, G, Rybo
openaire +2 more sources
American Journal of Obstetrics and Gynecology, 1971
Abstract A series of 215 menorrhagic women was treated with curettage, a uterus-contracting agent (methylergobaseinmaleate), ovulation inhibitors (combined contraceptive pills), and the antifibrinolytic agents epsilon aminocaproic acid (EACA) and tranexamic acid (AMCA). Another antifibrinolytic agent, paraaminomethyl-benzoic acid (PAMBA), was used in
L, Nilsson, G, Rybo
openaire +2 more sources
Abstract A series of 215 menorrhagic women was treated with curettage, a uterus-contracting agent (methylergobaseinmaleate), ovulation inhibitors (combined contraceptive pills), and the antifibrinolytic agents epsilon aminocaproic acid (EACA) and tranexamic acid (AMCA). Another antifibrinolytic agent, paraaminomethyl-benzoic acid (PAMBA), was used in
L, Nilsson, G, Rybo
openaire +2 more sources
Acta Obstetricia et Gynecologica Scandinavica, 2003
Menorrhagia is defined as a ‘complaint of heavy cyclical menstrual bleeding occurring over several consecutive cycles’. Objectively it is a total menstrual blood loss equal to or greater than 80 ml per menstruation. It is estimated that approximately 30% of women complain of menorrhagia.
M K, Oehler, M C P, Rees
openaire +2 more sources
Menorrhagia is defined as a ‘complaint of heavy cyclical menstrual bleeding occurring over several consecutive cycles’. Objectively it is a total menstrual blood loss equal to or greater than 80 ml per menstruation. It is estimated that approximately 30% of women complain of menorrhagia.
M K, Oehler, M C P, Rees
openaire +2 more sources
BMJ clinical evidence, 2016
Menorrhagia limits normal activities, and causes anaemia in two-thirds of women with objective menorrhagia (loss of 80 mL blood per cycle). Prostaglandin disorders may be associated with idiopathic menorrhagia, and with heavy bleeding due to fibroids, adenomyosis, or use of intrauterine devices (IUDs).
Joseph E. Pizzorno +2 more
openaire +4 more sources
Menorrhagia limits normal activities, and causes anaemia in two-thirds of women with objective menorrhagia (loss of 80 mL blood per cycle). Prostaglandin disorders may be associated with idiopathic menorrhagia, and with heavy bleeding due to fibroids, adenomyosis, or use of intrauterine devices (IUDs).
Joseph E. Pizzorno +2 more
openaire +4 more sources